1. Drugmaker Gilead reaches multiyear agreement with White House to donate HIV prevention med PrEP  CNBC
  2. A Generic Version of Truvada Will Be Available by 2020  NewNowNext
  3. Pharmaceutical Company To Donate Medication To Help End HIV Epidemic  HuffPost
  4. Gilead's $3B Truvada will face generics a year early. Can Descovy still win over its patients?  FiercePharma
  5. Up to 200,000 uninsured people may soon have access to HIV prevention medication  CNN
  6. View full coverage on Google News
Gilead will donate its PrEP medication Truvada, which is used to reduce the risk of HIV infection and usually sells for $1,600 to $2,000 a month in the United States.Gilead will donate its PrEP medication Truvada, which is used to reduce the risk of HIV infection and usually sells for $1,600 to $2,000 a month in the United States.

California-based Gilead Sciences Inc. has agreed to donate HIV prevention drugs that reduce the risk of HIV transmission for up to 200,000 people a year.California-based Gilead Sciences Inc. has agreed to donate HIV prevention drugs that reduce the risk of HIV transmission for up to 200,000 people a year.

Pharmaceutical Company To Donate Medication To Help End HIV Epidemic | HuffPost

Gilead's big-selling HIV drug Truvada wasn't supposed to see generic competition until 2021, or so executives have been saying. But in its latest quarterly filing, the company said Teva can roll its copy next year, giving Gilead less time to woo patients over to its newer drug Descovy.Gilead's big-selling HIV drug Truvada wasn't supposed to see generic competition until 2021, or so executives have been saying. But in its latest quarterly filing, the company said Teva can roll its copy next year, giving Gilead less time to woo patients over to its newer drug Descovy.

Gilead's $3B Truvada will face generics a year early. Can Descovy still win over its patients? | FiercePharma

The latest worldwide HIV/AIDS news and updates, including treatment, prevention, and hepatitis and TB co-infections.People buying generic PrEP (pre-exposure prophylaxis) online can be confident they are buying the real thing, according to research presented to the International Congress on Drug Therapy in HIV Infection (HIV Glasgow) today. Investigators in London tested the contents of branded Truvada and 13 generic samples of the tablet bought online. All contained the amounts of emtricitabine and tenofovir stated on the label. “We were able to confirm the stated content of PrEP tablets from various manufacturers and suppliers,” comment the investigators. “This study provides reassurance to the community purchasing generic PrEP online.” PrEP using tenofovir combined with emtricitabine can reduce the risk of infection with HIV by over 90%. However, the NHS in England provides only limited free access to PrEP, via the IMPACT trial. This means that many individuals who would potentially benefit from PrEP have resorted to purchasing generic versions of the therapy from online pharmacies. There is already some evidence that these individuals can have confidence in generic PrEP – a therapeutic drug monitoring study involving approximately 300 individuals using generic PrEP found plasma concentrations of emtricitabine and tenofovir above target levels. However, concern has been expressed in some quarters about the authenticity of generic PrEP purchased online. Investigators from Imperial College, PrEPster (a PrEP advocacy group) and Terrence Higgins Trust therefore tested the contents of generic PrEP from mainstream brands purchased from a range of online suppliers, measuring the amount of emtricitabine and tenofovir. A total of 14 samples were obtained, including branded Truvada and the generic products Tenvir-EM (Cipla), Ricovir-EM (Mylan), Tenof-EM (Hetero Healthcare), Teno-EM (GPO), Tavin-EM (Emcure) and Adco-Emtevir (Adcock Ingram). The online suppliers were Dynamix International, In House Pharmacy, Green Cross Pharmacy, United Pharmacy, All Day Chemist and Silom. The samples were bought directly from online suppliers and care was taken to ensure those placing the orders were not known to the online suppliers as PrEP activists. A fully validated assay was used to determine whether the samples contained the 200mg of emtricitabine and 300mg of tenofovir stated on the label. The scientist testing the samples was blinded to the origin of each sample. Branded Truvada contained 100% of the stated amounts of both drugs. The 13 generic samples contained between 97% and 104% of the claimed 200mg of emtricitabine and 94% to 105% of the stated amount of tenofovir. Ian Green, Chief Executive at Terrence Higgins Trust, commented: "These results clearly show that the PrEP being privately sourced online from the main suppliers is fit for purpose and therefore, when taken as prescribed, highly effective at preventing HIV. Understandably, those considering ordering PrEP online have some concerns about what they are buying and hopefully this will act as further reassurance."But this doesn’t change the fact that NHS England must make PrEP routinely available to those who need it. It’s unacceptable that many trial sites on the IMPACT Trial are now unable to provide PrEP for gay and bisexual men as no-one should be denied a pill which can prevent HIV as we work toward reaching zero HIV transmissions in this country."

HIV & AIDS Information :: Generic PrEP bought online has correct amounts of emtricitabine and tenofovir

Brand Name: Atripla Other Name(s): EFV/FTC/TDF, efavirenz/emtricitabine/tenofovir DF Drug Class: Combination Drugs...Brand Name: Atripla Other Name(s): EFV/FTC/TDF, efavirenz/emtricitabine/tenofovir DF Drug Class: Combination Drugs

Icon - Search

“Great news today: My Administration just secured a historic donation of HIV prevention drugs from Gilead to help expand access to PrEP for the uninsured and those at risk. Will help us achieve our goal of ending the HIV epidemic in America! https://t.co/wux5QasWgW”

Donald J. Trump on Twitter: "Great news today: My Administration just secured a historic donation of HIV prevention drugs from Gilead to help expand access to PrEP for the uninsured and those at risk. Will help us achieve our goal of ending the HIV epidemic in America!… https://t.co/UrRHsUJ20v"

“#DrugPricing query: If your drug is going generic one year early, do you give it away to maintain market share and undermine the competitor? @HHSGov announces $GILD to donate HIV prevention drug Truvada for 200K people/year through at least 2025. $TEVA”

Bertha Coombs on Twitter: "#DrugPricing query: If your drug is going generic one year early, do you give it away to maintain market share and undermine the competitor? @HHSGov announces $GILD to donate HIV prevention drug Truvada for 200K people/year through at least 2025. $TEVA… https://t.co/7LrjV5oBpX"

Gilead Sciences has agreed to break its patent a year earlier than anticipated.Gilead Sciences has agreed to break its patent a year earlier than anticipated.

A Generic Version of Truvada Will Be Available by 2020 | NewNowNext

President Trump on Thursday said that his administration secured a "historic" donation of the HIV-prevention drug Truvada for PrEP. President Trump on Thursday said that his administration secured a "historic" donation of the HIV-prevention drug Truvada for PrEP. 

Trump says administration secured 'historic donation' of HIV prevention drugs to help end epidemic | TheHill

President Trump on Thursday said that his administration secured a "historic" donation of the HIV-prevention drug Truvada for PrEP. President Trump on Thursday said that his administration secured a "historic" donation of the HIV-prevention drug Truvada for PrEP. 

Trump says administration secured 'historic donation' of HIV prevention drugs to help end epidemic | TheHill

Gilead Sciences’ agreement with the government is part of President Trump’s initiative to nearly wipe out HIV transmission in the United States by 2030.Gilead Sciences’ agreement with the government is part of President Trump’s initiative to nearly wipe out HIV transmission in the United States by 2030.

Drugmaker to donate HIV-prevention pills for as many as 200,000 people - The Washington Post

Activists hailed the earlier than expected release, calling it "a victory for the LGBTQ+ community, for HIV activists, and for U.S. taxpayers...Activists hailed the earlier than expected release, calling it "a victory for the LGBTQ+ community …

A generic version of PrEP will be available next year / LGBTQ Nation

Activists have complained that the price Gilead charges for its medicine has been a barrier to wider use and thwarted efforts to eradicate the virus.Activists have complained that the price Gilead charges for its medicine has been a barrier to wider use and thwarted efforts to eradicate the virus.

A generic version of a Gilead HIV pill coming sooner than expected- STAT

Pharmaceutical giant Gilead Sciences will donate the anti-HIV drug Truvada to the federal government so it can move toward its goal to eliminate HIV transmission in a decade.Pharmaceutical giant Gilead Sciences will donate the anti-HIV drug Truvada to the federal government so it can move toward its goal to eliminate HIV transmission in a decade.

Gilead donates anti-HIV drug for 200,000 people to help Trump initiative

Gilead Sciences, makers of HIV prevention drug Truvada, have announced that a generic version will be available as early as September 2020.Gilead Sciences, makers of HIV prevention drug Truvada, have announced that a generic version will be available as early as September 2020. Truvada, also called PrEP, is a daily pill that prevents

Generic version of HIV drug coming after activist campaign

Error 406 - Not Acceptable